NUVISAN IN A NUTSHELL

Introduction
- NUVISAN is a fully integrated contract research organization “from the molecule to the patient”
- With a track record of nearly four decades as one of the first German CROs (est. 1979)
- Capabilities are distributed over five locations in Germany and France
- Balanced client portfolio: pharmaceutical industry, biotech companies & academic institutions

Staff
- Headcount of 870 employees
- 40% of the staff are academics and 38% of these with PhD level
- High staff loyalty ensures business continuity during the project as also the opportunity build up reliable long-term relations

Quality Metrics
- >90% percent of our business is based on repeat business and reflects our clients satisfaction
- High quality was multiple times confirmed by various authority inspections (e.g. BfArM, EMA, FDA, ANVISA)
- 71 sponsor audits & inspections in 2022

SERVICE PORTFOLIO

Drug Discovery R&D Services
- Lead discovery & early development
- Medicinal and computational chemistry
- In vitro biology
- In vivo pharmacology
- DMPK & toxicology
- Biomarker Discovery

Analytical Labs
- Nonclinical & clinical PK/TK analysis
- Immunogenicity & biomarkers
- Central lab services

Non-Clinical Studies
- DMPK in discovery & development
- In vitro & in vivo PK studies
- Isotope/radiolabeling

Pharmaceutical Services
- QP services
- Clinical trial supply
- Formulation support
- Pharmaceutical testing

Clinical Trials
- In-house phase I/IIa
- Multicenter trial management
- Monitoring

Complementary & Standalone Services
- Consultancy
- Data management
- Data sciences
- Medical writing
- PK analysis